E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/9/2011 in the Prospect News PIPE Daily.

NeurogesX negotiates $20 million financing with Hercules Technology

Company gets $15 million loan and $5 million accounts receivable line

By Devika Patel

Knoxville, Tenn., Aug. 9 - NeurogesX, Inc. negotiated a $20 million financing agreement with Hercules Technology Growth Capital, Inc. on Aug. 5, according to an 8-K filed Tuesday with the Securities and Exchange Commission. The financing includes both a $5 million accounts receivable line and a $15 million term loan.

The $15 million term loan is required to be repaid over the course of 42 months, which includes a one-year interest-only period at the beginning of the term. Interest on the loan has a minimum rate of 9.5%, which can increase based on fluctuations in the Prime rate.

The $5 million accounts receivable line is a revolving line that is available until Dec. 31, 2012 and then is renewable by Hercules each year. The accounts receivable line bears interest at a minimum interest rate of 6.75%, which can also increase based on fluctuations in the Prime rate.

The company may prepay both the term loan and the accounts receivable line at any time, with a $600,000 fee when the term loan is repaid.

Hercules also received a warrant for 791,667 shares, which is exercisable at $1.80 for five years. The strike price reflects a 20.35% discount to the Aug. 4 closing share price of $2.26.

Based in San Carlos, Calif., NeurogesX is a specialty pharmaceutical company focused on neuropathic pain.

Issuer:NeurogesX, Inc.
Issue:Term loan, accounts receivable line
Amount:$20 million
Warrants:For 791,667 shares
Warrant expiration:Five years
Warrant strike price:$1.80
Investor:Hercules Technology Growth Capital, Inc.
Fees:$150,000
Settlement date:Aug. 5
Stock symbol:Nasdaq: NGSX
Stock price:$2.35 at close Aug. 5
Market capitalization:$38.61 million
Loan
Amount:$15 million
Maturity:42 months
Coupon:Floor of 9.5%, based on Prime
Call:With a $600,000 fee
Accounts receivable line
Amount:$5 million
Maturity:Dec. 31, 2012
Coupon:Floor of 6.75%, based on Prime
Call:Yes

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.